Title:
ＤＮＡ損傷応答のコンジュゲート阻害剤
Document Type and Number:
Japanese Patent JP2022546490
Kind Code:
A
Abstract:
本明細書において、疾患の治療において治療剤として使用するために好適なＤＮＡ損傷応答の阻害剤である放出可能なコンジュゲートを提供する。
More Like This:
| JP7075757 | ELP fusion protein for controlled and sustained release |
| JP2023505150 | Therapies for the treatment of cancer |
| WO/2004/080453 | ANTIHEPATITIS C VIRUS AGENT AND ANTI-HIV AGENT |
Inventors:
Fontaine, Sean D.
Hahn, Brian Earl
Santi, Daniel Buoy
Hahn, Brian Earl
Santi, Daniel Buoy
Application Number:
JP2022513556A
Publication Date:
November 04, 2022
Filing Date:
August 28, 2020
Export Citation:
Assignee:
Prolinks LLC
International Classes:
A61K31/407; A61K31/4184; A61K31/4523; A61K31/496; A61K31/497; A61K31/5025; A61K31/55; A61K31/551; A61K31/77; A61K47/60; A61P35/00; C07D231/56; C07D237/32; C07D403/04; C07D413/04; C07D471/06; C07D487/04; C07D491/052
Attorney, Agent or Firm:
Yamato Kento
Sei Morimoto
Nobuhiko Akiyama
Sei Morimoto
Nobuhiko Akiyama